[Prognostic value of palmitoyl-protein thioesterase-1 in gastric cancer and its regulatory role in tumor cell lipid metabolism].

Bingyi Huang Yu-Jie Gao Jing-Yi Xie Chen Yan Meng-Ru Gu Zhizhi Zhang Jin-Tao Guo Song Liu Ziliang Wang Yuping Yang L. Zuo De-Li Chen

Aug 2026 · Nan fang yi ke da xue xue bao = Journal of Southern Medical University · Vol 46 8, pp. 1915-1925 · 0 citations

Medicine

TL;DR

PPT1 overexpression promotes GC progression by activating the ERK signaling pathway and thereby modulating lipid metabolism, suggesting its potential as a novel prognostic biomarker and a therapeutic target for GC.

DOI PubMed Semantic Scholar

View source

Similar papers

Open access Aug 2026

TGFBR3 regulates the expression of FATP2-ACSL1 axis related proteins and accompanies changes in the migration and invasion ability of lung cancer cells

TGFBR3 interacts with FATP2 and is associated with the regulation of migration and invasion in lung cancer cells, potentially involving the FATP2-ACSL1 axis.

Tian Luo, Yuanyuan Wu, Nuoya Ma et al. · Frontiers in Oncology · 0 citations

Open access Sep 2026

P4HA3 promotes gastric cancer cell proliferation and invasion via the PI3K/AKT/mTOR signaling pathway and regulates glycolytic metabolic reprogramming

Experimental data indicated that P4HA3 facilitated GC cell proliferation, migration and invasion, and enhanced glycolytic activity and increased the expression of key glycolysis-related proteins, suggesting that P4HA3 may induce a broader metabolic activation rather than an exclusively glycolytic shift.

Tao Wang · Pakistan Journal of Pharmace... · 0 citations

Open access Aug 2026

Gene signatures of palmitoylation and fatty acid metabolism predict prognosis and immunotherapy response in breast cancer patients by machine learning, single-cell analysis, and experimental validation

The study identifies G6PD as a key metabolic gene linked to tumor progression; this finding not only offers potential insights into the molecular mechanisms of BRCA but also supports further exploration of metabolism-related therapeutic strategies.

Zhun Zhang, Ying Fu, Yu-Song Zhou et al. · Frontiers in Pharmacology · 0 citations

Open access Aug 2026

EPHX2 Expression and Its Association with Prognosis, Metabolic Regulation, and Metastasis-Related Pathways in Lung Adenocarcinoma

Bioinformatics analyses suggest that EPHX2 may participate in metabolic and tumor progression-related regulatory networks and may serve as a prognostic biomarker in LUAD.

Şebnem Yıldırımcan Kadıçeşme · Genes · 0 citations

Open access Sep 2026

FSCN1 Modulates Fatty Acid Metabolism and the Coordinated Activation of AKT/mTOR and p38 MAPK Pathways in Colorectal Cancer Cells

Findings link FSCN1 to the AKT/mTOR/SREBP1/(FASN/SCD1) lipogenic axis and the p38 MAPK/PPARα/ACOX1 peroxisomal FAO pathway, implicating FSCN1 in lipid metabolic regulation and CRC progression, while suggesting a putative functional regulatory axis and a promising candidate therapeutic target for CRC.

Zhen Li, Xin-Ya Yu, Bo-Ning Wu et al. · Oncology Research · 0 citations

Open access Sep 2026

HIST1H4L promotes small cell lung cancer tumorigenesis by regulating the PI3K/Akt pathway and serves as a potential diagnostic biomarker

HIST1H4L was significantly upregulated in SCLC tumors versus normal tissues and enriched in DNA transcription-related pathways and correlated with poor patient survival; critically, high HIST1H4L expression correlated with poor patient survival.

Shi-Cheng Feng, Min Feng, Zhi-Qiang Lu et al. · Frontiers in Oncology · 0 citations